Amit Bhalla - May 31, 2022 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Director
Signature
/s/ Erika L. Eves for Amit Bhalla, by power of attorney
Stock symbol
NAVB
Transactions as of
May 31, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 04:32 PM
Previous filing
May 3, 2022
Next filing
Jul 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +2.5K +4.5% $0.00 58.1K May 31, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
F2 Issuance deferred at the request of the Reporting Person.